Study: Women With Advanced Breast Cancer Can Double Survival
Middle East North Africa Financial Network
(MENAFN Press) A new study has revealed that women suffering from breast cancer can survive for twice as long without disease progression, or tumour growth, using the Novartis-made drug Afinitor® (everolimus) in conjunction with hormonal therapy. ...
Advancements in Treating Advanced Breast Cancers